/
Background Azitra, Inc. was formed as a Delaware corporation on January 2, 2014 as a biopharmaceutical company focused on developing innovative therapies for precision dermatology using engineered proteins and topical live biotherapeutic products. Since our formation, we have built a proprietary platform that includes a microbial library comprised of approximately 1,500 unique bacterial strains…
Revenue declined 100.0% YoY. The question is whether this is cyclical or a structural shift.
Negative free cash flow of -$11M. The business is consuming cash, not generating it.
Profitability & Returns
Revenue (FY)
$0.00
▼ -100.0% YoY
Net Income (TTM)
-$12M
▼ -22.2% YoY
Op. Margin
—
ROIC
-85.20%
▲ +7.3pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$11M
▼ -10.4% YoY
Op. Cash Flow (TTM)
-$11M
▼ -10.2% YoY
Net Debt
-$10M
Net Cash Position
Cash & Equiv.
$10M
Continue Research